Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Financial Flexibility Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of CN¥-44.49 Million (operating CF CN¥-149.12 Million minus capex CN¥104.63 Million) represents 0% of total liabilities (CN¥4.74 Billion). Check Hunan Dajiaweikang Pharmaceutical Indust (301126) asset resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 7 annual periods. See 301126 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full company profile including market capitalisation, see 301126 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | CN¥-44.49 Million | CN¥-149.12 Million | CN¥4.74 Billion | ▼ -119.2% |
| 2024 | 0.05x | CN¥211.18 Million | CN¥24.04 Million | CN¥4.33 Billion | ▼ -32.8% |
| 2023 | 0.07x | CN¥253.83 Million | CN¥27.13 Million | CN¥3.50 Billion | ▲ +153.8% |
| 2022 | -0.13x | CN¥-285.24 Million | CN¥-493.96 Million | CN¥2.11 Billion | ▼ -38.1% |
| 2021 | -0.10x | CN¥-128.52 Million | CN¥-161.81 Million | CN¥1.32 Billion | ▼ -7.5% |
| 2020 | -0.09x | CN¥-105.52 Million | CN¥-151.46 Million | CN¥1.16 Billion | ▼ -156.0% |
| 2019 | 0.16x | CN¥168.42 Million | CN¥135.91 Million | CN¥1.04 Billion | — |